Medical Condition News

RSS

Leading GP urges compassionate approach towards doctors, healthcare staff suffering burnout

Doctors, nurses and other healthcare staff suffering burnout should be shown compassion and not blamed for being unwell, according to a leading GP.

14 Jul 2024

Review highlights unique characteristics and mechanisms of ferroptosis

Junxia Min, Fudi Wang, et al., at Zhejiang University School of Medicine, China, provided an in-depth review on the programmed cell death known as ferroptosis, which is driven by iron-dependent lipid peroxidation.

14 Jul 2024

Poll: Majority of Brits fear cancer diagnosis more than any other condition

Two-thirds of the public say they are very or somewhat worried about being told they have the disease – higher than for any other medical condition, including dementia and having a heart attack – according to polling released today.

14 Jul 2024

Study finds dried fruit consumption lowers type 2 diabetes risk

Recent research shows that higher dried fruit intake is linked to a reduced risk of type 2 diabetes, highlighting potential health benefits despite its sugar content.

14 Jul 2024

Study offers insights on prevalence and risk factors of persistent post-COVID-19 symptoms

Early on during the coronavirus pandemic, there were reports of cases of persistent post-infection symptoms.

14 Jul 2024

AI analysis of Reddit reveals public interest in GLP-1 drugs for weight loss and mental health benefits

Researchers analyzed over 391,000 Reddit discussions using AI to study public perceptions of GLP-1 RAs, finding high interest in weight loss, side effects, and access issues, with mostly neutral-to-positive sentiment.

14 Jul 2024

New brain targets for GLP1-based obesity drugs may reduce weight without nausea

Researchers identified distinct hindbrain GLP1R neurons driving satiety and aversion, offering new targets for effective, side-effect-free obesity treatments.

14 Jul 2024

Lifestyle changes can greatly reduce heart disease risk in people with high genetic risk

Study highlights the significant impact of genetic risk and lifestyle on early- and late-onset cardiovascular diseases, showing that lifestyle improvements can notably reduce CVD risk, especially in high genetic risk individuals.

14 Jul 2024

New 3D model sheds light on amyloid-beta's impact

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have unveiled a pioneering study shedding light on the intricate mechanisms underlying Alzheimer's disease (AD). The study, titled "Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype," represents a significant leap forward in understanding the interplay between amyloid-like structures and neuronal cells.

13 Jul 2024

Antibody-drug conjugate shows preclinical efficacy

A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer."

13 Jul 2024

Study links OCD improvement to brain activity shift

A recent study from Baylor College of Medicine and Texas Children's Hospital has identified a specific neural activity pattern as a novel biomarker to accurately predict and monitor the clinical status of individuals with obsessive-compulsive disorder (OCD) who have undergone deep brain stimulation (DBS), a rapidly emerging therapeutic approach for severe psychiatric disorders. The study, led by led by Drs. Sameer Sheth and Wayne Goodman along with co-lead authors, Drs. Nicole Provenza, Sandy Reddy, and Anthony Allam, was published in Nature Medicine.

13 Jul 2024

Gene editing silences mutant microRNA, restores hearing in adult mice

Researchers have used gene editing to restore hearing in adult mice with a type of inherited hearing loss. They showed that shutting down a damaged copy of a gene called a microRNA (miRNA) enabled the animals to regain hearing. The approach by a research team supported by the National Institutes of Health (NIH), reported in Science Translational Medicine, may eventually lead to potential treatments for inherited hearing loss in people.

13 Jul 2024

Revolutionary AI model improves early dementia diagnosis

Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.

13 Jul 2024

Innovative AI diabetes training module gets national recognition

The development of a new artificial intelligence-based tool that supports health professionals caring for people with diabetes has led to national recognition for a Northumbria University researcher and her team.

13 Jul 2024

Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced that it has submitted its application to the U.S. Food and Drug Administration (FDA) requesting Breakthrough Device Designation for its non-invasive Next Generation colorectal cancer (CRC) product including the Company’s novel portfolio of mRNA biomarkers. Subject to the FDA’s review, a Breakthrough Device Designation could significantly accelerate approval.

13 Jul 2024

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, announced today that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England.

13 Jul 2024

New threshold for CXCL13 concentration revolutionizes neuroborreliosis diagnosis

A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis.

13 Jul 2024

WISDOM project leverages AI and data to combat chronic immune-mediated diseases in Europe

Integrating medical and research data, ensuring secure data sharing, and using advanced AI models offer immense possibilities to mitigate the impact of chronic immune-mediated diseases (CIMDs) affecting 10% of Europeans.

12 Jul 2024

Short and long sleep duration linked to microvascular disease in newly diagnosed diabetics

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Madrid, 9-13 September) shows that people recently diagnosed with diabetes who experience short or long sleep duration are more likely to experience microvascular disease (damage to the small blood vessels), which could ultimately lead to more serious complications.

12 Jul 2024

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Lichuan Wu et al., at Medical College of Guangxi University, China, presented a comprehensive study on the role of replication factor C subunit 4 (RFC4) in nasopharyngeal carcinoma (NPC), a type of epithelial cancer commonly associated with Epstein-Barr virus infection.

12 Jul 2024

Medical Condition News

Leading GP urges compassionate approach towards doctors, healthcare staff suffering burnout

Review highlights unique characteristics and mechanisms of ferroptosis

Poll: Majority of Brits fear cancer diagnosis more than any other condition

Study finds dried fruit consumption lowers type 2 diabetes risk

Study offers insights on prevalence and risk factors of persistent post-COVID-19 symptoms

AI analysis of Reddit reveals public interest in GLP-1 drugs for weight loss and mental health benefits

New brain targets for GLP1-based obesity drugs may reduce weight without nausea

Lifestyle changes can greatly reduce heart disease risk in people with high genetic risk

New 3D model sheds light on amyloid-beta's impact

Antibody-drug conjugate shows preclinical efficacy

Study links OCD improvement to brain activity shift

Gene editing silences mutant microRNA, restores hearing in adult mice

Revolutionary AI model improves early dementia diagnosis

Innovative AI diabetes training module gets national recognition

Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

New threshold for CXCL13 concentration revolutionizes neuroborreliosis diagnosis

WISDOM project leverages AI and data to combat chronic immune-mediated diseases in Europe

Short and long sleep duration linked to microvascular disease in newly diagnosed diabetics

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News